Dafalgan 500 mg, Tabletten
7680692660046
CH-69266
Tabletten
Associated product:
DAFALGAN cpr 500 mg 100 pce
1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.07 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 15.70
Specialties list
Yes
Generic
No
SL addition date:
01/10/2025
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69266
- Drug name
- Dafalgan, Tabletten
- Galenic form
- TAB
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 28/03/2024
- Authorization expiration date
- 27/03/2029
- IT Number
- 01.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DAFALGAN cpr 500 mg 100 pce
- Description (DE)
- DAFALGAN Tabl 500 mg 100 Stk
- Market launch
- 31/07/2025
- Narcotic (BTM)
- No